Skip to main content
RACS ASC 2025
Low rates of surgical recurrence following ileocolic resections for Crohn’s disease in the biologic era. Results of the PORSCIA multicentre Australian study
Verbal Presentation
Edit Your Submission
Edit

Verbal Presentation

5:12 pm

03 May 2025

Meeting Room C4.8

THE MARK KILLINGBACK RESEARCH PAPER PRIZE SESSION

Watch The Presentation
Presentation Description

Institution: Royal Prince Alfred Hospital - NSW, Australia

PURPOSE Ileocolic resections (ICR) are the most common resections for Crohn’s disease (CD). Historical control groups have often been used for comparison when assessing post-operative recurrence (POR), usually with temporal bias. This study aimed to: (i) report contemporary rates of POR requiring repeat surgery (surgical recurrence at anastomosis [SR-ICR], or at any site [SR-any]) and the rates of endoscopic recurrence (ER) in the ‘biologic era’; and (ii) determine risk factors for SR-ICR and ER. METHODOLOGY A retrospective multicentre study involving twelve tertiary Australian centres was performed. Cox proportional hazards modelling was used to evaluate clinico-pathological risk factors for SR-ICR and ER (defined as Rutgeerts Grade >/= i2b). RESULTS Overall, 911 patients who underwent an ICR for CD between 2007-2023 were included (mean 39.1yrs [SD 15.3], 52% F). Median follow-up was 63.7 months. Rates of SR-ICR were 4.5% (95%CI:2.8%-6.1%) and 12.8% (95%CI:8.8%-16.5%) at 5- and 10-years, respectively. Rates of SR-any were 5.6% (95%CI:3.8%-7.5%) and 15.1% (95%CI:11.0%-19.1%) at 5- and 10-years, respectively. Early (within 18-months) ER occurred in 23.5%. On multivariable analysis, smoking (aHR 3.49 [95%CI:1.93-6.29]) was the only factor significantly associated with SR-ICR. Smoking, positive microscopic margins and granulomas were associated with ER, and prophylactic therapy and younger age at diagnosis (<17 yrs) were protective. CONCLUSION The rate of SR at the ileocolic anastomosis in this large Australian cohort was low, recorded to be one-in-twenty at 5-years. Smoking remains the strongest risk factor for both ER and SR. Histopathological factors influence ER and should be considered in future risk prediction models.
Presenters
Authors
Authors

Dr Hugh Giddings - , Dr Kheng-Seong Ng - , Prof Michael Solomon - , Dr Arteen Arzivian - , Dr Craig Haifer - , Dr Huiyu Lin - , Dr Christian Pappas - , Prof David Clark - , Dr Anthony Deacon - , Prof Graham Radford-Smith - , Dr Nargus Ebrahimi - , Dr Ann Wu - , Dr Mark Lewis - , Dr Roscoe Lim - , Dr Jennifer Zhang - , Dr Abhinav Vasudevan - , Dr Kathryn Demase - , Dr Jadon Karp - , Dr Richard Fernandes - , Dr Yoon-Kyo An - , Dr Zi Qin Ng - , Dr Scott Mackenzie - , Dr Lena Thin - , Dr Tessa Greeve - , A/Prof Gregory Moore - , Prof Susan Connor - , Prof Jane Andrews - , A/Prof Miles Sparrow - , Dr Simon Ghaly -